The Foundry, started by MIT biological engineering professor Christopher Voigt and Broad Technology Labs (BTL) director Robert Nicol, is the result of a partnership between BTL and the Synthetic Biology Center of MIT, of which Voigt is co-director. The Foundry enables the rapid design, testing, and fabrication of large sequences of genetic information so they […]
The MIT Center for Integrative Synthetic Biology was established and funded in September 2013 as part of the NIH-NIGMS national centers for systems biology. A key feature of CISB is to focus on interdisciplinary and collaborative research into next-generation therapeutics. The MIT-CISB will create the therapeutics of the future by integrating systems biology and synthetic biology. The grant awarded to CISB will enable core group of researchers at MIT to focus on three medically relevant research subjects positioned at the intersection of systems and synthetic biology:
- Cancer therapy
- Artificial tissue homeostasis
- Infectious disease
By integrating top-down systems views of disease with bottom-up synthetic construction of novel treatments, this community will create new disease therapies with the ability to integrate multiple inputs and deliver specific interventions.